Navigation Links
BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock

ProductsBioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
Company BioPro Implants
Item BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
Features 
  • Femoral component available in five sizes, left and right.
  • Porous coated femoral component.
  • Polyethylene tibial inserts available in three thinknesses per size.
  • Tibial inserts available in four sizes.
  • Description The Femoral component of the unicompartmental knee offers less soft tissue and bony destruction which means quicker rehabilitation with a high rate of long term success. The implant allows for minimum bone resection and offers multiple thickness polyethylene inserts to accommodate varying tibial plateau deficiencies.
    Info BioPro Implants
    Customer Service: (800) 252-7707
    Web site: http://www.bioproimplants.com/home.asp

    Related medicine products :

    1. BioPro® Modular TKO (Total Knee Original), PCL Retaining
    2. BioPro® TKO (Total Knee Original), Bi-Cruciate Retaining
    3. Scorpio CR Knee, cruciate retaining single axis
    4. Laserex Tango M (Total Mobile Version)
    5. Bilirubin, Direct & Total
    6. Bilirubin Total Reagent
    7. Total Bilirubin Reagent
    8. Total Protein
    9. Total Protein Reagent
    10. Total Protein Reagent Set
    11. Iron Total (TIBC)
    ... technique, recommended for the treatment of ... direct inguinal hernias, provides significant advantages ... less overall dissection and is utilized ... The result is increased patient comfort, ...
    ... System is a sterile, pre-shaped, three-dimensional device ... a mesh cylinder to a circular underlay ... unique and innovative design combines the three ... in the repair of inguinal hernias. ,Its ...
    ... The 800 Series KTP/YAG Surgical ... hospital market. It is a high-power, ... ENT, plastic surgery, orthopedics, general surgery, ... The KTP/532 beam surgically cuts, vaporizes ...
    ... a new, portable, light weight, high power ... cosmetic and plastic surgery, general surgery, ENT ... resurfacing, it is the smallest, yet among ... market. It provides an ideal treatment for ...
    Medicine Products:
    (Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
    (Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
    (Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
    (Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
    (Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
    Breaking Medicine News(10 mins):
    (Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
    (Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
    (Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
    Breaking Medicine Technology: